|
Central nervous system (CNS) diseases studied with OCT | Study type (target) | Applications | References |
|
Multiple sclerosis (MS) | Clinical (human retina) | Diagnostic biomarker development, measuring outcome of drug trials | [64, 65] |
|
Optic neuritis (ON) | Clinical (human retina) | Diagnostic biomarker development, measuring outcome of drug trials | [17, 66, 67] |
|
Parkinson’s disease (PD) | Clinical (human retina) | Diagnostic biomarker development, measuring disease severity | [26, 68] |
Nonclinical (rodent brain) | Guiding deep brain stimulation therapy | [69] |
|
Alzheimer’s disease (AD) | Clinical (human retina) | Diagnostic biomarker development | [26, 70] |
|
Schizophrenia | Clinical (human retina) | Diagnostic biomarker development | [25, 71] |
|
Optic nerve edema | Clinical (human retina) | Diagnostic biomarker development | [25] |
|
Optic neuropathies (hereditary/toxic/nutritional) | Clinical (human retina) | Diagnostic biomarker development | [25] |
|
Glaucoma | Clinical (human retina) | Diagnostic biomarker development, measuring outcome of drug trials | [25, 72] |
|
Amblyopia | Clinical (human retina) | Studying retinal involvement | [25] |
|
Neurosarcoidosis | Clinical (human retina) | Studying retinal involvement | [25] |
|
Obstructive sleep apnea-hypopnea syndrome | Clinical (human retina) | Studying retinal involvement | [25] |
|
Friedreich’s ataxia | Clinical (human retina) | Studying retinal involvement | [25] |
|
Amyotrophic lateral sclerosis (ALS) | Clinical (human retina) | Diagnostic biomarker development | [73] |
|
Gaucher disease | Clinical (human retina) | Diagnostic biomarker development | [74] |
|
Bipolar disorder | Clinical (human retina, ganglion cell layer) | Diagnostic biomarker development | [75] |
|
Sialidosis | Clinical (human retina) | Studying retinal involvement | [76] |
|
Stroke (hemorrhagic/ischemic) | Nonclinical (rodent brain) | Studying stroke recovery | [3, 77–79] |
|
Epilepsy | Clinical (human retina) | Studying drug resistance, studying retinal involvement | [80, 81] |
Nonclinical (rodent brain) | Epilepsy mapping | [82] |
|
Traumatic brain injury (TBI) | Nonclinical (rodent brain) | Studying TBI recovery | [3, 83, 84] |
|
Brain tumor | Clinical (human brain, ex vivo human brain tissue) | Intraoperative neurosurgery guidance, diagnostic assessment | [5, 18, 85] |
Nonclinical (rodent brain) | Intraoperative neurosurgery guidance | [18, 22, 86] |
|
Usher syndrome | Clinical (human retina) | Studying retinal involvement | [87] |
|
Huntington’s disease | Clinical (human retina) | Studying retinal involvement | [88] |
|
Wilson’s disease | Clinical (human retina) | Studying retinal involvement | [89] |
|
Migraine | Clinical (human retina) | Diagnostic biomarker development | [25] |
|